… relating to their vaccination state and previous SARS-COV-2 infection. In the samples
collected we only measured the anti-SARS-COV-2 antibodies, eliminating the remaining sample. …

… of antibodies directed against the SARS-CoV-2 … antibody responses to SARS-CoV-2 infection
or vaccination. The qualitative and quantitative analysis of antibodies against SARS-CoV-2 …

… -2 belongs to the same large family of viruses as those that caused the MERS and SARS
outbreak, we could assume that its antibody generation process is similar. During the outbreak …

… We have low confidence in these findings given the limitations of the evidence base, including
small study sizes, inconsistent adjustment for confounding factors, and lack of precision in …

… , IgA, IgG and/or IgM) with follow-up duration of greater than 28 days (which we defined as
the limit of the acute phase of illness). Shorter follow-up studies were included if they reported …

… OC43 N correlated with lower IgG to SARS-CoV-2 N in rRT-PCR … Antibodies to SARS-CoV-2
N were higher in patients with … of SARS-CoV-2-specific and HCoV crossreactive antibodies, …

… outstanding linearity for range of values within and above the cut-off points, rendering it
especially useful for vaccinated individuals where antibody values are above the detection limit […

… SARS donor and isolated multiple RBD-specific antibodies that neutralize and protect
against SARS-CoV, SARS-CoV-2, … antibodies that target two distinct domains of the SARS-CoV-2 …

… Clinicians should consider the risks and benefits of SARS-CoV-2 antibody testing for
individuals, and share information about the limitations of testing with patients (box 1). High quality …

… coronavirus 2 (SARS-CoV-2)—has heated up. Medical diagnostic companies are scrambling,
and governments are looking to order these antibody … Yet, there is a palpable hurry to limit …